COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry - UAE
Contacts
Partner
United Arab Emirates
I am the Head of Country for the UAE, the Head of Intellectual Property for the Middle East, and the global co-head of Franchising. I've practised in the UAE since 2006 and I'm ranked in IP Stars, Chambers & Partners, Legal 500 and Who's Who Legal for my commercial and intellectual property experience.
Partner
United Arab Emirates
I am a partner in the Corporate Group based in Dubai, where I lead M&A transactions and deliver sophisticated employment law advice to clients.
Related
Sectors
Trending Topics
Countries
Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the United Arab Emirates.
COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of Bird & Bird's International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located. This update aims to provide guidance on the responses of EU, Asia-Pac and UAE regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.
